Answer
No, the safety and efficacy of palopegteriparatide (Yorvipath) in children under 18 have not yet been established, and no data are available.
Sources for this answer
- Yorvipath 294 micrograms/0.98 mL solution for injection in pre filled penAscendis Pharma UK Limited · emc · SmPC §4.2 Posology and method of administration · Version 4Document updated
Sources checked